+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Endocrinology Drugs Market 2024-2028

  • PDF Icon

    Report

  • 177 Pages
  • May 2024
  • Region: Global
  • TechNavio
  • ID: 4938432
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The endocrinology drugs market is forecasted to grow by USD 36.83 billion during 2023-2028, accelerating at a CAGR of 7.45% during the forecast period. The report on the endocrinology drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in incidence of endocrine disorders, promising pipeline for endocrinology, and research in novel dosage formulations and drug delivery systems.

The endocrinology drugs market is segmented as below:

By Therapy Area

  • Diabetes drugs
  • hGH
  • Thyroid hormone disorders
  • Others

By Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the association between obesity and endocrine disorders as one of the prime reasons driving the endocrinology drugs market growth during the next few years. Also, use of biosimilars for endocrine disorders and growing geriatric population will lead to sizable demand in the market.

The report on the endocrinology drugs market covers the following areas:

  • Endocrinology drugs market sizing
  • Endocrinology drugs market forecast
  • Endocrinology drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading endocrinology drugs market vendors that include Abbott Laboratories, Acerus Pharmaceuticals Corp., Ascendis Pharma AS, Bayer AG, Beta Cell NV, Biocon Ltd., Eli Lilly and Co., Endo International Plc, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Hanmi Pharm Co. Ltd., Ipsen Pharma, Merck and Co. Inc., Novartis AG, Novo Nordisk AS, Oramed Pharmaceuticals Inc., Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and VeroScience LLC. Also, the endocrinology drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Therapy Area
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Endocrinology Drugs Market 2018 - 2022
Historic Market Size - Data Table on Global Endocrinology Drugs Market 2018 - 2022 ($ million)
4.2 Therapy Area segment analysis 2018 - 2022
Historic Market Size - Therapy Area Segment 2018 - 2022 ($ million)
4.3 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Therapy Area
6.1 Market segments
Chart on Therapy Area - Market share 2023-2028 (%)
Data Table on Therapy Area - Market share 2023-2028 (%)
6.2 Comparison by Therapy Area
Chart on Comparison by Therapy Area
Data Table on Comparison by Therapy Area
6.3 Diabetes drugs - Market size and forecast 2023-2028
Chart on Diabetes drugs - Market size and forecast 2023-2028 ($ million)
Data Table on Diabetes drugs - Market size and forecast 2023-2028 ($ million)
Chart on Diabetes drugs - Year-over-year growth 2023-2028 (%)
Data Table on Diabetes drugs - Year-over-year growth 2023-2028 (%)
6.4 hGH - Market size and forecast 2023-2028
Chart on hGH - Market size and forecast 2023-2028 ($ million)
Data Table on hGH - Market size and forecast 2023-2028 ($ million)
Chart on hGH - Year-over-year growth 2023-2028 (%)
Data Table on hGH - Year-over-year growth 2023-2028 (%)
6.5 Thyroid hormone disorders - Market size and forecast 2023-2028
Chart on Thyroid hormone disorders - Market size and forecast 2023-2028 ($ million)
Data Table on Thyroid hormone disorders - Market size and forecast 2023-2028 ($ million)
Chart on Thyroid hormone disorders - Year-over-year growth 2023-2028 (%)
Data Table on Thyroid hormone disorders - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Therapy Area
Market opportunity by Therapy Area ($ million)
Data Table on Market opportunity by Therapy Area ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacies - Market size and forecast 2023-2028
Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
7.4 Retail pharmacies - Market size and forecast 2023-2028
Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
7.5 Online pharmacies - Market size and forecast 2023-2028
Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape2023-2028 (%)
Data Table on Market share By Geographical Landscape2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity By Geographical Landscape($ million)
Data Tables on Market opportunity By Geographical Landscape($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Acerus Pharmaceuticals Corp.
Acerus Pharmaceuticals Corp. - Overview
Acerus Pharmaceuticals Corp. - Product / Service
Acerus Pharmaceuticals Corp. - Key offerings
12.4 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.5 Beta Cell NV
Beta Cell NV - Overview
Beta Cell NV - Product / Service
Beta Cell NV - Key offerings
12.6 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.7 Endo International Plc
Endo International Plc - Overview
Endo International Plc - Business segments
Endo International Plc - Key news
Endo International Plc - Key offerings
Endo International Plc - Segment focus
12.8 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.9 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.10 Hanmi Pharm Co. Ltd.
Hanmi Pharm Co. Ltd. - Overview
Hanmi Pharm Co. Ltd. - Product / Service
Hanmi Pharm Co. Ltd. - Key offerings
12.11 Ipsen Pharma
Ipsen Pharma - Overview
Ipsen Pharma - Business segments
Ipsen Pharma - Key offerings
Ipsen Pharma - Segment focus
12.12 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
12.13 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.14 Novo Nordisk AS
Novo Nordisk AS - Overview
Novo Nordisk AS - Business segments
Novo Nordisk AS - Key offerings
Novo Nordisk AS - Segment focus
12.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.16 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
12.17 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Therapy Area
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Endocrinology Drugs Market 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Therapy Area Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on Therapy Area - Market share 2023-2028 (%)
Exhibits 33: Data Table on Therapy Area - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by Therapy Area
Exhibits 35: Data Table on Comparison by Therapy Area
Exhibits 36: Chart on Diabetes drugs - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Data Table on Diabetes drugs - Market size and forecast 2023-2028 ($ million)
Exhibits 38: Chart on Diabetes drugs - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Diabetes drugs - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on hGH - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on hGH - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on hGH - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on hGH - Year-over-year growth 2023-2028 (%)
Exhibits 44: Chart on Thyroid hormone disorders - Market size and forecast 2023-2028 ($ million)
Exhibits 45: Data Table on Thyroid hormone disorders - Market size and forecast 2023-2028 ($ million)
Exhibits 46: Chart on Thyroid hormone disorders - Year-over-year growth 2023-2028 (%)
Exhibits 47: Data Table on Thyroid hormone disorders - Year-over-year growth 2023-2028 (%)
Exhibits 48: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 49: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 52: Market opportunity by Therapy Area ($ million)
Exhibits 53: Data Table on Market opportunity by Therapy Area ($ million)
Exhibits 54: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 55: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 56: Chart on Comparison by Distribution Channel
Exhibits 57: Data Table on Comparison by Distribution Channel
Exhibits 58: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits 60: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 62: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 65: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 66: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits 68: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 69: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 70: Market opportunity by Distribution Channel ($ million)
Exhibits 71: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 73: Chart on Market share By Geographical Landscape2023-2028 (%)
Exhibits 74: Data Table on Market share By Geographical Landscape2023-2028 (%)
Exhibits 75: Chart on Geographic comparison
Exhibits 76: Data Table on Geographic comparison
Exhibits 77: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 102: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 103: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 106: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 107: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 109: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 110: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 111: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 112: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 113: Market opportunity By Geographical Landscape($ million)
Exhibits 114: Data Tables on Market opportunity By Geographical Landscape($ million)
Exhibits 115: Impact of drivers and challenges in 2023 and 2028
Exhibits 116: Overview on criticality of inputs and factors of differentiation
Exhibits 117: Overview on factors of disruption
Exhibits 118: Impact of key risks on business
Exhibits 119: Companies covered
Exhibits 120: Matrix on companies position and classification
Exhibits 121: Acerus Pharmaceuticals Corp. - Overview
Exhibits 122: Acerus Pharmaceuticals Corp. - Product / Service
Exhibits 123: Acerus Pharmaceuticals Corp. - Key offerings
Exhibits 124: Bayer AG - Overview
Exhibits 125: Bayer AG - Business segments
Exhibits 126: Bayer AG - Key news
Exhibits 127: Bayer AG - Key offerings
Exhibits 128: Bayer AG - Segment focus
Exhibits 129: Beta Cell NV - Overview
Exhibits 130: Beta Cell NV - Product / Service
Exhibits 131: Beta Cell NV - Key offerings
Exhibits 132: Eli Lilly and Co. - Overview
Exhibits 133: Eli Lilly and Co. - Product / Service
Exhibits 134: Eli Lilly and Co. - Key news
Exhibits 135: Eli Lilly and Co. - Key offerings
Exhibits 136: Endo International Plc - Overview
Exhibits 137: Endo International Plc - Business segments
Exhibits 138: Endo International Plc - Key news
Exhibits 139: Endo International Plc - Key offerings
Exhibits 140: Endo International Plc - Segment focus
Exhibits 141: F. Hoffmann La Roche Ltd. - Overview
Exhibits 142: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 143: F. Hoffmann La Roche Ltd. - Key news
Exhibits 144: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 145: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 146: GlaxoSmithKline Plc - Overview
Exhibits 147: GlaxoSmithKline Plc - Business segments
Exhibits 148: GlaxoSmithKline Plc - Key news
Exhibits 149: GlaxoSmithKline Plc - Key offerings
Exhibits 150: GlaxoSmithKline Plc - Segment focus
Exhibits 151: Hanmi Pharm Co. Ltd. - Overview
Exhibits 152: Hanmi Pharm Co. Ltd. - Product / Service
Exhibits 153: Hanmi Pharm Co. Ltd. - Key offerings
Exhibits 154: Ipsen Pharma - Overview
Exhibits 155: Ipsen Pharma - Business segments
Exhibits 156: Ipsen Pharma - Key offerings
Exhibits 157: Ipsen Pharma - Segment focus
Exhibits 158: Merck and Co. Inc. - Overview
Exhibits 159: Merck and Co. Inc. - Business segments
Exhibits 160: Merck and Co. Inc. - Key news
Exhibits 161: Merck and Co. Inc. - Key offerings
Exhibits 162: Merck and Co. Inc. - Segment focus
Exhibits 163: Novartis AG - Overview
Exhibits 164: Novartis AG - Business segments
Exhibits 165: Novartis AG - Key news
Exhibits 166: Novartis AG - Key offerings
Exhibits 167: Novartis AG - Segment focus
Exhibits 168: Novo Nordisk AS - Overview
Exhibits 169: Novo Nordisk AS - Business segments
Exhibits 170: Novo Nordisk AS - Key offerings
Exhibits 171: Novo Nordisk AS - Segment focus
Exhibits 172: Pfizer Inc. - Overview
Exhibits 173: Pfizer Inc. - Product / Service
Exhibits 174: Pfizer Inc. - Key news
Exhibits 175: Pfizer Inc. - Key offerings
Exhibits 176: Sanofi SA - Overview
Exhibits 177: Sanofi SA - Business segments
Exhibits 178: Sanofi SA - Key news
Exhibits 179: Sanofi SA - Key offerings
Exhibits 180: Sanofi SA - Segment focus
Exhibits 181: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 182: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 183: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 184: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 185: Inclusions checklist
Exhibits 186: Exclusions checklist
Exhibits 187: Currency conversion rates for US$
Exhibits 188: Research methodology
Exhibits 189: Information sources
Exhibits 190: Data validation
Exhibits 191: Validation techniques employed for market sizing
Exhibits 192: Data synthesis
Exhibits 193: 360 degree market analysis
Exhibits 194: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global endocrinology drugs market: Abbott Laboratories, Acerus Pharmaceuticals Corp., Ascendis Pharma AS, Bayer AG, Beta Cell NV, Biocon Ltd., Eli Lilly and Co., Endo International Plc, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Hanmi Pharm Co. Ltd., Ipsen Pharma, Merck and Co. Inc., Novartis AG, Novo Nordisk AS, Oramed Pharmaceuticals Inc., Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and VeroScience LLC.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is association between obesity and endocrine disorders."

According to the report, one of the major drivers for this market is the increase in incidence of endocrine disorders.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Acerus Pharmaceuticals Corp.
  • Ascendis Pharma AS
  • Bayer AG
  • Beta Cell NV
  • Biocon Ltd.
  • Eli Lilly and Co.
  • Endo International Plc
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Hanmi Pharm Co. Ltd.
  • Ipsen Pharma
  • Merck and Co. Inc.
  • Novartis AG
  • Novo Nordisk AS
  • Oramed Pharmaceuticals Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.
  • VeroScience LLC